Table of Contents Author Guidelines Submit a Manuscript
International Journal of Inflammation
Volume 2014 (2014), Article ID 509707, 14 pages
http://dx.doi.org/10.1155/2014/509707
Review Article

Vasospasm in Cerebral Inflammation

Luton and Dunstable University Hospital NHS Foundation Trust, Lewsey Road, Luton LU4ODZ, UK

Received 13 September 2014; Accepted 8 December 2014; Published 29 December 2014

Academic Editor: Jean-Marc Cavaillon

Copyright © 2014 Michael Eisenhut. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Weir, “The pathophysiology of cerebral vasospasm,” British Journal of Neurosurgery, vol. 9, no. 3, pp. 375–390, 1995. View at Publisher · View at Google Scholar · View at Scopus
  2. H. Bode and A. Harders, “Transient stenoses and occlusions of main cerebral arteries in children—diagnosis and control of therapy by transcranial Doppler sonography,” European Journal of Pediatrics, vol. 148, no. 5, pp. 406–411, 1989. View at Publisher · View at Google Scholar · View at Scopus
  3. K.-F. Lindegaard, H. Nornes, S. J. Bakke, W. Sorteberg, and P. Nakstad, “Cerebral vasospasm diagnosis by means of angiography and blood velocity measurements,” Acta Neurochirurgica, vol. 100, no. 1-2, pp. 12–24, 1989. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Lysakowski, B. Walder, M. C. Costanza, and M. R. Tramèr, “Transcranial Doppler versus angiography in patients with vasospasm due to a ruptured cerebral aneurysm: a systematic review,” Stroke, vol. 32, no. 10, pp. 2292–2298, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. R. L. Grubb Jr., M. E. Raichle, J. O. Eichling, and M. H. Gado, “Effects of subarachnoid hemorrhage on cerebral blood volume, blood flow and oxygen utilization in humans,” Journal of Neurosurgery, vol. 46, no. 4, pp. 446–452, 1977. View at Publisher · View at Google Scholar · View at Scopus
  6. C.-H. Lu, H.-W. Chang, C.-C. Lui, C.-R. Huang, and W.-N. Chang, “Cerebral haemodynamics in acute bacterial meningitis in adults,” Quaterly Journal of Medicine, vol. 99, no. 12, pp. 863–869, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. F. Faraci and D. D. Heistad, “Regulation of the cerebral circulation: role of endothelium and potassium channels,” Physiological Reviews, vol. 78, no. 1, pp. 53–97, 1998. View at Google Scholar · View at Scopus
  8. L. Hektoen, “The vascular changes in tuberculous meningitis especially in tuberculous endarteritis,” Journal of Experimental Medicine, vol. 1, pp. 112–163, 1896. View at Publisher · View at Google Scholar
  9. G. Thwaites, “Tuberculosis of the central nervous system,” in Clinical Tuberculosis, P. D. O. Davies, S. B. Gordon, and G. Davies, Eds., pp. 151–165, CRC Press, 5th edition, 2014. View at Google Scholar
  10. P. M. Dalal, “Observations on the involvement of cerebral vessels in tuberculous meningitis in adults,” Advances in Neurology, vol. 25, pp. 149–159, 1979. View at Google Scholar · View at Scopus
  11. L. A. Rojas-Echeverri, J. L. Soto-Hernández, S. Garza et al., “Predictive value of digital subtraction angiography in patients with tuberculous meningitis,” Neuroradiology, vol. 38, no. 1, pp. 20–24, 1996. View at Publisher · View at Google Scholar · View at Scopus
  12. E. L. Lyons and N. E. Leeds, “The angiographic demonstration of arterial vascular disease in purulent meningitis: report of a case,” Radiology, vol. 88, no. 5, pp. 935–938, 1967. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Ries, U. Schminke, K. Fassbender, M. Daffertshofer, W. Steinke, and M. Hennerici, “Cerebrovascular involvement in the acute phase of bacterial meningitis,” Journal of Neurology, vol. 244, no. 1, pp. 51–55, 1997. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Fassbender, S. Ries, U. Schminke, S. Schneider, and M. Hennerici, “Inflammatory cytokines in CSF in bacterial meningitis: association with altered blood flow velocities in basal cerebral arteries,” Journal of Neurology, Neurosurgery & Psychiatry, vol. 61, no. 1, pp. 57–61, 1996. View at Publisher · View at Google Scholar · View at Scopus
  15. L. A. Pfister, J. H. Tureen, S. Shaw et al., “Endothelin inhibition improves cerebral blood flow and is neuroprotective in pneumococcal meningitis,” Annals of Neurology, vol. 47, pp. 329–335, 2000. View at Google Scholar
  16. S. L. Leib, Y. S. Kim, S. M. Black, J. H. Tureen, and M. G. Täuber, “Inducible nitric oxide synthase and the effect of aminoguanidine in experimental neonatal meningitis,” The Journal of Infectious Diseases, vol. 177, no. 3, pp. 692–700, 1998. View at Publisher · View at Google Scholar · View at Scopus
  17. T. W. Polder, C. R. Jerusalem, and W. M. C. Eling, “Morphological characteristics of intracerebral arterioles in clinical (Plasmodium falciparum) and experimental (Plasmodium berghei) cerebral malaria,” Journal of the Neurological Sciences, vol. 101, no. 1, pp. 35–46, 1991. View at Publisher · View at Google Scholar · View at Scopus
  18. N. A. V. Beare, S. P. Harding, T. E. Taylor, S. Lewallen, and M. E. Molyneux, “Perfusion abnormalities in children with cerebral malaria and malarial retinopathy,” Journal of Infectious Diseases, vol. 199, no. 2, pp. 263–271, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. C. R. J. C. Newton, K. Marsh, N. Peshu, and F. J. Kirkham, “Perturbations of cerebral hemodynamics in Kenyans with cerebral malaria,” Pediatric Neurology, vol. 15, no. 1, pp. 41–49, 1996. View at Publisher · View at Google Scholar · View at Scopus
  20. C. C. John, A. Panoskaltsis-Mortari, R. O. Opoka et al., “Cerebrospinal fluid cytokine levels and cognitive impairment in cerebral malaria,” American Journal of Tropical Medicine and Hygiene, vol. 78, no. 2, pp. 198–205, 2008. View at Google Scholar · View at Scopus
  21. W. McGuire, A. V. S. Hill, C. E. M. Allsopp, B. M. Greenwood, and D. Kwiatkowski, “Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria,” Nature, vol. 371, no. 6497, pp. 508–510, 1994. View at Publisher · View at Google Scholar · View at Scopus
  22. W. McGuire, J. C. Knight, A. V. S. Hill, C. E. M. Allsopp, B. M. Greenwood, and D. Kwiatkowski, “Severe malarial anemia and cerebral malaria are associated with different tumor necrosis factor promoter alleles,” Journal of Infectious Diseases, vol. 179, no. 1, pp. 287–290, 1999. View at Publisher · View at Google Scholar · View at Scopus
  23. B. Dugas, M. D. Mossalayi, C. Damais, and J.-P. Kolb, “Nitric oxide production by human monocytes: Evidence for a role of CD23,” Immunology Today, vol. 16, no. 12, pp. 574–580, 1995. View at Publisher · View at Google Scholar · View at Scopus
  24. L. Pellettieri, B. Nilsson, C.-A. Carlsson, and U. Nilsson, “Serum immunocomplexes in patients with subarachnoid hemorrhage,” Neurosurgery, vol. 19, no. 5, pp. 767–771, 1986. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Eisenhut, “Causes of reduced immune complex clearance in cerebral malaria,” Parasite Immunology, vol. 31, no. 2, p. 59, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. P. Teeranaipong, J. Ohashi, J. Patarapotikul et al., “A functional single-nucleotide polymorphism in the CR1 promoter region contributes to protection against cerebral malaria,” Journal of Infectious Diseases, vol. 198, no. 12, pp. 1880–1891, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. P. Cabrales, G. M. Zanini, D. Meays, J. A. Frangos, and L. J. M. Carvalho, “Murine cerebral malaria is associated with a vasospasm-like microcirculatory dysfunction, and survival upon rescue treatment is markedly increased by nimodipine,” The American Journal of Pathology, vol. 176, no. 3, pp. 1306–1315, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. I. Gramaglia, P. Sobolewski, D. Meays et al., “Low nitric oxide bioavailability contributes to the genesis of experimental cerebral malaria,” Nature Medicine, vol. 12, no. 12, pp. 1417–1422, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. T. W. Yeo, D. A. Lampah, E. Tjitra et al., “Relationship of cell-free hemoglobin to impaired endothelial nitric oxide bioavailability and perfusion in severe falciparum malaria,” Journal of Infectious Diseases, vol. 200, no. 10, pp. 1522–1529, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. G. Dhangadamajhi, B. N. Mohapatra, S. K. Kar, and M. Ranjit, “Genetic variation in neuronal nitric oxide synthase (nNOS) gene and susceptibility to cerebral malaria in Indian adults,” Infection, Genetics and Evolution, vol. 9, no. 5, pp. 908–911, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. M. R. Hobbs, V. Udhayakumar, M. C. Levesque et al., “A new NOS2 promoter polymorphism associated with increased nitric oxide production and protection from severe malaria in Tanzanian and Kenyan children,” The Lancet, vol. 360, no. 9344, pp. 1468–1475, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. P. Cabrales, G. M. Zanini, D. Meays, J. A. Frangos, and L. J. M. Carvalho, “Nitric oxide protection against murine cerebral malaria is associated with improved cerebral microcirculatory physiology,” The Journal of Infectious Diseases, vol. 203, no. 10, pp. 1454–1463, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. G. Morahan, C. S. Boutlis, D. Huang et al., “A promoter polymorphism in the gene encoding interleukin-12 p40 (IL12B) is associated with mortality from cerebral malaria and with reduced nitric oxide production,” Genes & Immunity, vol. 3, no. 7, pp. 414–418, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. C. Casals-Pascual, R. Idro, N. Gicheru et al., “High levels of erythropoietin are associated with protection against neurological sequelae in African children with cerebral malaria,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 7, pp. 2634–2639, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. F. C. Chow, C. M. Marra, and T. A. Cho, “Cerebrovascular disease in central nervous system infections,” Seminars in Neurology, vol. 31, no. 3, pp. 286–306, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. R. A. Armonda, R. S. Bell, A. H. Vo et al., “Wartime traumatic cerebral vasospasm: recent review of combat casualties,” Neurosurgery, vol. 59, no. 6, pp. 1215–1225, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. K. Shahlaie, K. Keachie, I. M. Hutchins et al., “Risk factors for posttraumatic vasospasm: clinical article,” Journal of Neurosurgery, vol. 115, no. 3, pp. 602–611, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. Y. Udomphorn, W. M. Armstead, and M. S. Vavilala, “Cerebral blood flow and autoregulation after pediatric traumatic brain injury,” Pediatric Neurology, vol. 38, no. 4, pp. 225–234, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. R. M. Pluta, J. Hansen-Schwartz, J. Dreier et al., “Cerebral vasospasm following subarachnoid hemorrhage: time for a new world of thought,” Neurological Research, vol. 31, no. 2, pp. 151–158, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. J. Hansen-Schwartz, P. Vajkoczy, R. L. Macdonald, R. M. Pluta, and J. H. Zhang, “Cerebral vasospasm: looking beyond vasoconstriction,” Trends in Pharmacological Sciences, vol. 28, no. 6, pp. 252–256, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. H. Kasuya, B. K. A. Weir, M. Nakane et al., “Nitric oxide synthase and guanylate cyclase levels in canine basilar artery after subarachnoid hemorrhage,” Journal of Neurosurgery, vol. 82, no. 2, pp. 250–255, 1995. View at Publisher · View at Google Scholar · View at Scopus
  42. M. D. Linnik and T. J. F. Lee, “Effect of hemoglobin on neurogenic responses and cholinergic parameters in porcine cerebral arteries,” Journal of Cerebral Blood Flow and Metabolism, vol. 9, no. 2, pp. 219–225, 1989. View at Publisher · View at Google Scholar · View at Scopus
  43. C. G. Sobey and F. M. Faraci, “Subarachnoid haemorrhage: what happens to the cerebral arteries?” Clinical and Experimental Pharmacology and Physiology, vol. 25, no. 11, pp. 867–876, 1998. View at Publisher · View at Google Scholar · View at Scopus
  44. Y. R. T. Dinh, G. Lot, R. Benrabah, O. Baroudy, J. Cophignon, and J. Seylaz, “Abnormal cerebral vasodilation in aneurysmal subarachnoid hemorrhage: use of serial 133Xe cerebral blood flow measurement plus acetazolamide to assess cerebral vasospasm,” Journal of Neurosurgery, vol. 79, no. 4, pp. 490–493, 1993. View at Publisher · View at Google Scholar · View at Scopus
  45. T. J. F. Lee, “Nitric oxide and the cerebral vascular function,” Journal of Biomedical Science, vol. 7, no. 1, pp. 16–26, 2000. View at Publisher · View at Google Scholar · View at Scopus
  46. M. Stoodley, R. L. Macdonald, B. Weir et al., “Subarachnoid hemorrhage as a cause of an adaptive response in cerebral arteries,” Journal of Neurosurgery, vol. 93, no. 3, pp. 463–470, 2000. View at Publisher · View at Google Scholar · View at Scopus
  47. Y. R. Tran Dinh, A. Jomaa, J. Callebert et al., “Overexpression of cyclooxygenase-2 in rabbit basilar artery endothelial cells after subarachnoid hemorrhage,” Neurosurgery, vol. 48, no. 3, pp. 626–635, 2001. View at Publisher · View at Google Scholar · View at Scopus
  48. Á. Gecse, B. Kis, Z. Mezei, and G. Telegdy, “Effects of inflammatory neuropeptides on the arachidonate cascade of platelets,” International Archives of Allergy and Immunology, vol. 118, no. 2–4, pp. 166–170, 1999. View at Publisher · View at Google Scholar · View at Scopus
  49. K. S. Mark, W. J. Trickler, and D. W. Miller, “Tumor necrosis factor-α induces cyclooxygenase-2 expression and prostaglandin release in brain microvessel endothelial cells,” Journal of Pharmacology and Experimental Therapeutics, vol. 297, no. 3, pp. 1051–1058, 2001. View at Google Scholar · View at Scopus
  50. T. Tanazawa, Y. Suzuki, M. Anzai, S. Tsugane, M. Takayasu, and M. Shibuya, “Vasodilation by intrathecal lipopolysaccharide of the cerebral arteries after subarachnoid haemorrhage in dogs,” Acta Neurochirurgica, vol. 138, no. 3, pp. 330–337, 1996. View at Publisher · View at Google Scholar · View at Scopus
  51. N. Toda, M. Kawakami, and K. Yoshida, “Constrictor action of oxyhemoglobin in monkey and dog basilar arteries in vivo and in vitro,” American Journal of Physiology: Heart and Circulatory Physiology, vol. 260, no. 2, pp. H420–H425, 1991. View at Google Scholar · View at Scopus
  52. M. Yoshizumi, M. A. Perrella, J. C. Burnett Jr., and M.-E. Lee, “Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life,” Circulation Research, vol. 73, no. 1, pp. 205–209, 1993. View at Publisher · View at Google Scholar · View at Scopus
  53. A. Rengasamy and R. A. Johns, “Regulation of nitric oxide synthase by nitric oxide,” Molecular Pharmacology, vol. 44, no. 1, pp. 124–128, 1993. View at Google Scholar · View at Scopus
  54. A. L. de Souza, A. C. P. de Oliveira, C. C. Romano, J. Sztajnbok, A. J. S. Duarte, and A. C. Seguro, “Interleukin-6 activation in ischemic stroke caused by Neisseria meningitidis serogroup C,” International Journal of Cardiology, vol. 127, no. 3, pp. e160–e163, 2008. View at Publisher · View at Google Scholar · View at Scopus
  55. T. Kandabashi, H. Shimokawa, K. Miyata et al., “Inhibition of myosin phosphatase by upregulated Rho-kinase plays a key role for coronary artery spasm in a porcine model with interleukin-1β,” Circulation, vol. 101, no. 11, pp. 1319–1323, 2000. View at Publisher · View at Google Scholar · View at Scopus
  56. D.-H. Nam, J.-S. Kim, S.-C. Hong et al., “Expression of interleukin-1β in lipopolysaccharide stimulated monocytes derived from patients with aneurysmal subarachnoid hemorrhage is correlated with cerebral vasospasm,” Neuroscience Letters, vol. 312, no. 1, pp. 41–44, 2001. View at Publisher · View at Google Scholar · View at Scopus
  57. A. Ito, H. Shimokawa, T. Kadokami et al., “Tyrosine kinase inhibitor suppresses coronary arteriosclerotic changes and vasospastic responses induced by chronic treatment with interleukin-1β in pigs in vivo,” Journal of Clinical Investigation, vol. 96, no. 3, pp. 1288–1294, 1995. View at Publisher · View at Google Scholar · View at Scopus
  58. H. Yanamoto, H. Kataoka, Y. Nakajo, and K. Iihara, “The role of the host defense system in the development of cerebral vasospasm: analogies between atherosclerosis and subarachnoid hemorrhage,” European Neurology, vol. 68, no. 6, pp. 329–343, 2012. View at Publisher · View at Google Scholar · View at Scopus
  59. A. F. Ducruet, P. R. Gigante, Z. L. Hickman et al., “Genetic determinants of cerebral vasospasm, delayed cerebral ischemia, and outcome after aneurysmal subarachnoid hemorrhage,” Journal of Cerebral Blood Flow & Metabolism, vol. 30, no. 4, pp. 676–688, 2010. View at Publisher · View at Google Scholar · View at Scopus
  60. J. Langham, C. Goldfrad, G. Teasdale, D. Shaw, and K. Rowan, “Calcium channel blockers for acute traumatic brain injury,” Cochrane Database Systematic Reviews, no. 4, Article ID CD000565, 2000. View at Google Scholar · View at Scopus
  61. S. M. Dorhout Mees, G. J. Rinkel, V. L. Feigin et al., “Calcium antagonists for aneurysmal subarachnoid haemorrhage,” Cochrane Database of Systematic Reviews, no. 3, Article ID CD000277, 2007. View at Google Scholar · View at Scopus
  62. R.-Q. Huang, F.-G. Jiang, Z.-M. Feng, and T.-Y. Wang, “Nicardipine in the treatment of aneurysmal subarachnoid haemorrhage: a meta-analysis of published data,” Acta Neurologica Belgica, vol. 113, no. 1, pp. 3–6, 2013. View at Publisher · View at Google Scholar · View at Scopus
  63. S. Naidu, A. J. Payne, J. Moodley, M. Hoffmann, and E. Gouws, “Randomised study assessing the effect of phenytoin and magnesium sulphate on maternal cerebral circulation in eclampsia using transcranial Doppler ultrasound,” British Journal of Obstetrics & Gynaecology, vol. 103, no. 2, pp. 111–116, 1996. View at Publisher · View at Google Scholar · View at Scopus
  64. D. Reddy, A. Fallah, J.-A. Petropoulos, F. Farrokhyar, R. L. Macdonald, and D. Jichici, “Prophylactic magnesium sulphate for aneurysmal subarachnoid haemorrhage: a systematic review and meta-analysis,” Neurocritical Care, vol. 21, no. 2, pp. 356–364, 2014. View at Publisher · View at Google Scholar · View at Scopus
  65. C. M. Bradford, S. Finfer, A. O'Connor et al., “A randomised controlled trial of induced hypermagnesaemia following aneurysmal subarachnoid haemorrhage,” Critical Care and Resuscitation, vol. 15, no. 2, pp. 119–125, 2013. View at Google Scholar · View at Scopus
  66. S.-H. Su, W. Xu, J. Hai, Y.-F. Wu, and F. Yu, “Effects of statins-use for patients with aneurysmal subarachnoid hemorrhage: a meta-analysis of randomized controlled trials,” Scientific Reports, vol. 4, article 4573, 2014. View at Publisher · View at Google Scholar · View at Scopus
  67. J. Guo, Z. Shi, K. Yang, J. H. Tian, and L. Jiang, “Endothelin receptor antagonists for subarachnoid hemorrhage,” Cochrane Database of Systematic Reviews, vol. 9, Article ID CD008354, 2012. View at Google Scholar · View at Scopus
  68. J. Shen, J.-W. Pan, Z.-X. Fan, X.-X. Xiong, and R.-Y. Zhan, “Dissociation of vasospasm-related morbidity and outcomes in patients with aneurysmal subarachnoid hemorrhage treated with clazosentan: a meta-analysis of randomized controlled trials: a review,” Journal of Neurosurgery, vol. 119, no. 1, pp. 180–189, 2013. View at Publisher · View at Google Scholar · View at Scopus
  69. P. Gomis, J. P. Graftieaux, R. Sercombe, D. Hettler, B. Scherpereel, and P. Rousseaux, “Randomized, double-blind, placebo-controlled, pilot trial of high-dose methylprednisolone in aneurysmal subarachnoid hemorrhage,” Journal of Neurosurgery, vol. 112, no. 3, pp. 681–688, 2010. View at Publisher · View at Google Scholar · View at Scopus
  70. A. H. Kramer and J. J. Fletcher, “Locally-administered intrathecal thrombolytics following aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis,” Neurocritical Care, vol. 14, no. 3, pp. 489–499, 2011. View at Publisher · View at Google Scholar · View at Scopus
  71. G. J. Liu, Z. J. Wang, Y. F. Wang et al., “Systematic assessment and meta-analysis of the efficacy and safety of fasudil in the treatment of cerebral vasospasm in patients with subarachnoid hemorrhage,” European Journal of Clinical Pharmacology, vol. 68, no. 2, pp. 131–139, 2012. View at Publisher · View at Google Scholar · View at Scopus
  72. S. Zhang, L. Wang, M. Liu, and B. Wu, “Tirilazad for aneurysmal subarachnoid haemorrhage,” Cochrane Database Systematic Review, vol. 2, Article ID CD006778, 2010. View at Google Scholar · View at Scopus
  73. M.-Y. Tseng, P. J. Hutchinson, H. K. Richards et al., “Acute systemic erythropoietin therapy to reduce delayed ischemic deficits following aneurysmal subarachnoid hemorrhage: a phase II randomized, double-blind, placebo-controlled trial: clinical article,” Journal of Neurosurgery, vol. 111, no. 1, pp. 171–180, 2009. View at Publisher · View at Google Scholar · View at Scopus
  74. H. Kasuya, “Development of nicardipine prolonged-release implants after clipping for preventing cerebral vasospasm: from laboratory to clinical trial,” Acta Neurochirurgica, Supplementum, vol. 115, pp. 41–44, 2013. View at Publisher · View at Google Scholar · View at Scopus
  75. C. Thomé, M. Seiz, G. A. Schubert et al., “Nicardipine pellets for the prevention of cerebral vasospasm,” Acta Neurochirurgica, no. 110, pp. 209–211, 2011. View at Publisher · View at Google Scholar · View at Scopus
  76. T. Nassar, S. Akkawi, A. Shina et al., “In vitro and in vivo effects of tPA and PAI-1 on blood vessel tone,” Blood, vol. 103, no. 3, pp. 897–902, 2004. View at Publisher · View at Google Scholar · View at Scopus
  77. T. Sugawara, R. Ayer, V. Jadhav, W. Chen, T. Tsubokawa, and J. H. Zhang, “Mechanisms of statin treatment in cerebral vasospasm,” Acta Neurochirurgica, no. 110, pp. 9–11, 2011. View at Publisher · View at Google Scholar · View at Scopus
  78. M. D. Vergouwen, R. J. De Haan, M. Vermeulen, and Y. B. Roos, “Effect of statin treatment on vasospasm, delayed cerebral ischemia, and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis update,” Stroke, vol. 41, no. 1, pp. e47–e52, 2010. View at Publisher · View at Google Scholar · View at Scopus
  79. G. E. Thwaites, N. D. Bang, N. H. Dung et al., “Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults,” The New England Journal of Medicine, vol. 351, no. 17, pp. 1741–1811, 2004. View at Publisher · View at Google Scholar · View at Scopus
  80. G. E. Thwaites, J. Macmullen-Price, T. T. H. Chau et al., “Serial MRI to determine the effect of dexamethasone on the cerebral pathology of tuberculous meningitis: an observational study,” The Lancet Neurology, vol. 6, no. 3, pp. 230–236, 2007. View at Publisher · View at Google Scholar · View at Scopus
  81. U. K. Misra, J. Kalita, and P. P. Nair, “Role of aspirin in tuberculous meningitis: a randomized open label placebo controlled trial,” Journal of the Neurological Sciences, vol. 293, no. 1-2, pp. 12–17, 2010. View at Publisher · View at Google Scholar · View at Scopus
  82. P. W. G. Elbers and C. Ince, “Bench-to-bedside review: mechanisms of critical illness—classifying microcirculatory flow abnormalities in distributive shock,” Critical Care, vol. 10, article 221, 2006. View at Publisher · View at Google Scholar · View at Scopus
  83. S. Trzeciak, I. Cinel, R. P. Dellinger et al., “Resuscitating the microcirculation in sepsis: the central role of nitric oxide, emerging concepts for novel therapies, and challenges for clinical trials,” Academic Emergency Medicine, vol. 15, no. 5, pp. 399–415, 2008. View at Publisher · View at Google Scholar · View at Scopus
  84. Y. Sakr, M.-J. Dubois, D. De Backer, J. Creteur, and J.-L. Vincent, “Persistent-microcirculatory alterations are associated with organ failure and death in patients with septic shock,” Critical Care Medicine, vol. 32, no. 9, pp. 1825–1831, 2004. View at Publisher · View at Google Scholar · View at Scopus
  85. P. E. Spronk, J. H. Rommes, C. Schaar, and C. Ince, “Thrombolysis in fulminant purpura: observations on changes in microcirculatory perfusion during succesful treatment,” Thrombosis and Haemostasis, vol. 95, no. 3, pp. 576–578, 2006. View at Publisher · View at Google Scholar · View at Scopus
  86. J. Creteur, D. De Backer, Y. Sakr, M. Koch, and J.-L. Vincent, “Sublingual capnometry tracks microcirculatory changes in septic patients,” Intensive Care Medicine, vol. 32, no. 4, pp. 516–523, 2006. View at Publisher · View at Google Scholar · View at Scopus
  87. D. De Backer, J. Creteur, J. C. Preiser, M. J. Dubois, and J. L. Vincent, “Microvascular blood flow is altered in patients with sepsis,” American Journal of Respiratory and Critical Care Medicine, vol. 166, no. 1, pp. 98–104, 2002. View at Publisher · View at Google Scholar · View at Scopus
  88. G. M. Ibrahim and R. L. Macdonald, “The effects of fluid balance and colloid administration on outcomes in patients with aneurysmal subarachnoid hemorrhage: a propensity score-matched analysis,” Neurocritical Care, vol. 19, no. 2, pp. 140–149, 2013. View at Publisher · View at Google Scholar · View at Scopus
  89. T. W. Yeo, D. A. Lampah, R. Gitawati et al., “Impaired nitric oxide bioavailability and L-arginine-reversible endothelial dysfunction in adults with falciparum malaria,” The Journal of Experimental Medicine, vol. 204, no. 11, pp. 2693–2704, 2007. View at Publisher · View at Google Scholar · View at Scopus
  90. A. R. Fathi, R. M. Pluta, K. D. Bakhtian, M. Qi, and R. R. Lonser, “Reversal of cerebral vasospasm via intravenous sodium nitrite after subarachnoid hemorrhage in primates: laboratory investigation,” Journal of Neurosurgery, vol. 115, no. 6, pp. 1213–1220, 2011. View at Publisher · View at Google Scholar · View at Scopus
  91. D. de Backer, J. Creteur, M. J. Dubois et al., “The effects of dobutamine on microcirculatory alterations in patients with septic shock are independent of its systemic effects,” Critical Care Medicine, vol. 34, no. 2, pp. 403–408, 2006. View at Publisher · View at Google Scholar · View at Scopus
  92. C. E. Chapleau, R. P. White, and J. T. Robertson, “Cerebral vasospasm: effects of prostaglandin synthetase inhibitors in vitro,” Neurosurgery, vol. 6, no. 2, pp. 155–159, 1980. View at Publisher · View at Google Scholar · View at Scopus
  93. J. L. Frazier, G. Pradilla, P. P. Wang, and R. J. Tamargo, “Inhibition of cerebral vasospasm by intracranial delivery of ibuprofen from a controlled-release polymer in a rabbit model of subarachnoid hemorrhage,” Journal of Neurosurgery, vol. 101, no. 1, pp. 93–98, 2004. View at Publisher · View at Google Scholar · View at Scopus
  94. G. Pradilla, Q. A. Thai, F. G. Legnani et al., “Local delivery of ibuprofen via controlled-release polymers prevents angiographic vasospasm in a monkey model of subarachnoid hemorrhage,” Neurosurgery, vol. 57, no. 1, pp. 184–189, 2005. View at Publisher · View at Google Scholar · View at Scopus
  95. R. P. White and J. T. Robertson, “Comparison of piroxicam, meclofenamate, ibuprofen, aspirin, and prostacyclin efficacy in a chronic model of cerebral vasospasm,” Neurosurgery, vol. 12, no. 1, pp. 40–46, 1983. View at Publisher · View at Google Scholar · View at Scopus
  96. T. Fukumori, E. Tani, Y. Maeda, and A. Sukenaga, “Effects of prostacyclin and indomethacin on experimental delayed cerebral vasospasm,” Journal of Neurosurgery, vol. 59, no. 5, pp. 829–834, 1983. View at Publisher · View at Google Scholar · View at Scopus
  97. L. Brandt, B. Ljunggren, K.-E. Andersson, B. Hindfelt, and T. Uski, “Prostaglandin metabolism and prostacyclin in cerebral vasospasm,” General Pharmacology, vol. 14, no. 1, pp. 141–143, 1983. View at Publisher · View at Google Scholar · View at Scopus
  98. T. Hakan, M. Zafer Berkman, T. Ersoy, I. Karataş, T. Şan, and S. Arbak, “Anti-inflammatory effect of meloxicam on experimental vasospasm in the rat femoral artery,” Journal of Clinical Neuroscience, vol. 15, no. 1, pp. 55–59, 2008. View at Publisher · View at Google Scholar · View at Scopus
  99. L. G. Toussaint III, J. A. Friedman, E. F. M. Wijdicks et al., “Influence of aspirin on outcome following aneurysmal subarachnoid hemorrhage,” Journal of Neurosurgery, vol. 101, no. 6, pp. 921–925, 2004. View at Publisher · View at Google Scholar · View at Scopus
  100. B. A. Gross, P. M. R. Lai, K. U. Frerichs, and R. Du, “Aspirin and aneurysmal subarachnoid haemorrhage,” World Neurosurgery, 2013. View at Publisher · View at Google Scholar
  101. S. Yokobori, A. Watanabe, R. Nakae et al., “Cerebral vasospasms after intraventricular hemorrhage from an arteriovenous malformation—case report,” Neurologia Medico-Chirurgica, vol. 50, no. 4, pp. 320–323, 2010. View at Publisher · View at Google Scholar · View at Scopus
  102. B. S. Park, Y. S. Won, S. S. Choi, and B. M. Kim, “Severe symptomatic vasospasm following intraventricular hemorrhage from arteriovenous fistula,” Journal of Korean Neurosurgical Society, vol. 45, no. 5, pp. 300–302, 2009. View at Publisher · View at Google Scholar · View at Scopus
  103. G. Pradilla, T. Garzon-Muvdi, J. J. Ruzevick et al., “Systemic L-citrulline prevents cerebral vasospasm in haptoglobin 2-2 transgenic mice after subarachnoid hemorrhage,” Neurosurgery, vol. 70, no. 3, pp. 747–757, 2012. View at Publisher · View at Google Scholar · View at Scopus
  104. G. Chen, J. Wu, C. Sun et al., “Potential role of JAK2 in cerebral vasospasm after experimental subarachnoid hemorrhage,” Brain Research, vol. 1214, pp. 136–144, 2008. View at Publisher · View at Google Scholar · View at Scopus
  105. C. L. Lin, A. L. Kwan, A. S. Dumont et al., “Attenuation of experimental subarachnoid hemorrhage-induced increases in circulating intercellular adhesion molecule-1 and cerebral vasospasm by the endothelin-converting enzyme inhibitor CGS 26303,” Journal of Neurosurgery, vol. 106, no. 3, pp. 442–448, 2007. View at Publisher · View at Google Scholar · View at Scopus
  106. K. Iseda, S. Ono, K. Onoda et al., “Antivasospastic and antiinflammatory effects of caspase inhibitor in experimental subarachnoid hemorrhage,” Journal of Neurosurgery, vol. 107, no. 1, pp. 128–135, 2007. View at Publisher · View at Google Scholar · View at Scopus
  107. C.-L. Lin, A. S. Dumont, T. Calisaneller, A.-L. Kwan, S.-L. Hwong, and K. S. Lee, “Monoclonal antibody against E selectin attenuates subarachnoid hemorrhage-induced cerebral vasospasm,” Surgical Neurology, vol. 64, no. 3, pp. 201–206, 2005. View at Publisher · View at Google Scholar · View at Scopus
  108. R. Echigo, N. Shimohata, K. Karatsu et al., “Trehalose treatment suppresses inflammation, oxidative stress, and vasospasm induced by experimental subarachnoid hemorrhage,” Journal of Translational Medicine, vol. 10, no. 1, article 80, 2012. View at Publisher · View at Google Scholar · View at Scopus
  109. C. Wakade, M. D. King, M. D. Laird, C. H. Alleyne Jr., and K. M. Dhandapani, “Curcumin attenuates vascular inflammation and cerebral vasospasm after subarachnoid hemorrhage in mice,” Antioxidants & Redox Signaling, vol. 11, no. 1, pp. 35–45, 2009. View at Publisher · View at Google Scholar · View at Scopus